- $18.56m
- $6.76m
- $2.03m
- 42
- 10
- 61
- 30
Annual income statement for DURECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 30.1 | 14 | 19.3 | 2.59 | 2.03 |
| Cost of Revenue | |||||
| Gross Profit | 28.7 | 12 | 17.7 | 2.32 | 1.95 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 42.7 | 48.3 | 54.4 | 42.3 | 20.9 |
| Operating Profit | -12.6 | -34.3 | -35.1 | -39.7 | -18.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -14.3 | -36.3 | -35.3 | -27.6 | -18.4 |
| Net Income After Taxes | -14.3 | -36.3 | -35.3 | -27.6 | -18.4 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -0.582 | -36.3 | -35.3 | -27.6 | -8.32 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.582 | -36.3 | -35.3 | -27.6 | -8.32 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.719 | -1.61 | -1.55 | -1.05 | -0.595 |